metformin has been researched along with Meningeal Neoplasms in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Meningeal Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "-based Clinical Practice Research Datalink (CPRD) to analyse diabetes status, duration of diabetes, glycemic control, and use of metformin, sulfonylureas, and insulin in relation to the risk of meningioma." | 7.85 | Diabetes, use of metformin, and the risk of meningioma. ( Becker, C; Bogdahn, U; Hau, P; Jick, SS; Leitzmann, MF; Meier, CR; Proescholdt, M; Seliger, C, 2017) |
| "-based Clinical Practice Research Datalink (CPRD) to analyse diabetes status, duration of diabetes, glycemic control, and use of metformin, sulfonylureas, and insulin in relation to the risk of meningioma." | 3.85 | Diabetes, use of metformin, and the risk of meningioma. ( Becker, C; Bogdahn, U; Hau, P; Jick, SS; Leitzmann, MF; Meier, CR; Proescholdt, M; Seliger, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seliger, C | 1 |
| Meier, CR | 1 |
| Becker, C | 1 |
| Jick, SS | 1 |
| Proescholdt, M | 1 |
| Bogdahn, U | 1 |
| Hau, P | 1 |
| Leitzmann, MF | 1 |
| Wilisch-Neumann, A | 1 |
| Pachow, D | 1 |
| Wallesch, M | 1 |
| Petermann, A | 1 |
| Böhmer, FD | 1 |
| Kirches, E | 1 |
| Mawrin, C | 1 |
2 other studies available for metformin and Meningeal Neoplasms
| Article | Year |
|---|---|
Diabetes, use of metformin, and the risk of meningioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Child, Preschool; Databases | 2017 |
Re-evaluation of cytostatic therapies for meningiomas in vitro.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dacarbazine; DNA Methylation; DNA Modification M | 2014 |